Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1180242 | 0.81 | CYP1A2 (0.38) | IDO1 | |
| SCHEMBL24925406 | 0.79 | TSHR (0.31) | IDO1 | |
| SCHEMBL14249405 | 0.67 | RAB9A (0.35) | RAB9ASMN1; SMN2 | |
| SCHEMBL18338406 | 0.65 | SMN1; SMN2 (0.34) | RAB9ASMN1; SMN2 | |
| SCHEMBL24730818 | 0.62 | MAPKAPK2 (0.34) | IDO1 | |
| SCHEMBL24730822 | 0.62 | MAPKAPK2 (0.34) | IDO1 | |
| SCHEMBL1180985 | 0.59 | IDO1 (0.32) | IDO1 | |
| SCHEMBL25082072 | 0.59 | — | — | |
| SCHEMBL1737418 | 0.59 | IDO1 (0.34) | IDO1SMN1; SMN2 | |
| SCHEMBL18338385 | 0.56 | CYP1A2 (0.44) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230014226-A1 | NEW COMPOUNDS AND METHODS | BENEVOLENTAI BIO LIMITED (GB) | 2023-01-19 | — | — | US | disclosed |
| CN-114340734-A | Novel compounds and methods | 博善人工智能生物科技有限公司 | 2022-04-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230014226-A1 | NEW COMPOUNDS AND METHODS | ABL2, ABL1, ALK | IDO1 2511/4885RAB9A 1661/4885SMN1; SMN2 2246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.